These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11840834)

  • 21. Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins.
    Actis-Goretta L; Ottaviani JI; Keen CL; Fraga CG
    FEBS Lett; 2003 Dec; 555(3):597-600. PubMed ID: 14675780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of angiotensin-converting enzyme in canine testis.
    Sabeur K; Vo AT; Ball BA
    Reproduction; 2001 Jul; 122(1):139-46. PubMed ID: 11425338
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A scheme for determining the correct activity of the kinetic angiotensin-converting enzyme.
    Buttery JE; Chamberlain BR
    Clin Chem; 1985 Apr; 31(4):645-6. PubMed ID: 2983907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A fluorescence-based protocol for quantifying angiotensin-converting enzyme activity.
    Sentandreu MA; Toldrá F
    Nat Protoc; 2006; 1(5):2423-7. PubMed ID: 17406486
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological activity of an amino analogue of a tripeptide inhibitor of angiotensin-converting enzyme.
    Almquist RG; Christie PH; Chao WR; Johnson HL
    J Pharm Sci; 1983 Jan; 72(1):63-7. PubMed ID: 6298401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed-type inhibition of bovine lung angiotensin converting enzyme by lisinopril and its dansyl derivative.
    Uçar G; Ozer I
    Biochem Pharmacol; 1992 Aug; 44(3):565-70. PubMed ID: 1324678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin I converting enzyme activity in rabbit corneal endothelial cells.
    Neels HM; Vanden Berghe DA; Neetens AJ; Delgadillo RA; Scharpe SL
    Ophthalmologica; 1983; 187(2):129-32. PubMed ID: 6310465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving efficiency of an angiotensin converting enzyme inhibitory peptide as multifunctional peptides.
    Tanzadehpanah H; Asoodeh A; Saidijam M; Chamani J; Mahaki H
    J Biomol Struct Dyn; 2018 Nov; 36(14):3803-3818. PubMed ID: 29173094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The functional role of tyrosine-200 in human testis angiotensin-converting enzyme.
    Chen YN; Ehlers MR; Riordan JF
    Biochem Biophys Res Commun; 1992 Apr; 184(1):306-9. PubMed ID: 1314588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study of substrate specificity of a new peptide substrate of endothelin converting enzyme].
    Gureeva TA; Kugaevskaia EV; Pozdnev VF; Prozorovskiĭ VN; Eliseeva IuE; Solov'eva NI
    Biomed Khim; 2007; 53(2):172-80. PubMed ID: 17639718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimized determination of angiotensin I-converting enzyme activity with hippuryl-L-histidyl-L-leucine as substrate.
    Schnaith E; Beyrau R; Bückner B; Klein RM; Rick W
    Clin Chim Acta; 1994 Jun; 227(1-2):145-58. PubMed ID: 7955411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substrate specificity and kinetic characteristics of angiotensin converting enzyme.
    Bünning P; Holmquist B; Riordan JF
    Biochemistry; 1983 Jan; 22(1):103-10. PubMed ID: 6299330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distribution of angiotensin converting enzyme in human tissues.
    van Sande ME; Scharpé SL; Neels HM; Van Camp KO
    Clin Chim Acta; 1985 Apr; 147(3):255-60. PubMed ID: 2581725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different contributions of the angiotensin-converting enzyme C-domain and N-domain in subjects with the angiotensin-converting enzyme II and DD genotype.
    van Esch JH; van Gool JM; de Bruin RJ; Payne JR; Montgomery HE; Hectors M; Deinum J; Dive V; Jan Danser AH
    J Hypertens; 2008 Apr; 26(4):706-13. PubMed ID: 18327080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
    Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
    FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substrate dependence of angiotensin I-converting enzyme inhibition: captopril displays a partial selectivity for inhibition of N-acetyl-seryl-aspartyl-lysyl-proline hydrolysis compared with that of angiotensin I.
    Michaud A; Williams TA; Chauvet MT; Corvol P
    Mol Pharmacol; 1997 Jun; 51(6):1070-6. PubMed ID: 9187274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assay of angiotensin I-converting enzyme-inhibiting activity based on the detection of 3-hydroxybutyric acid.
    Lam le H; Shimamura T; Sakaguchi K; Noguchi K; Ishiyama M; Fujimura Y; Ukeda H
    Anal Biochem; 2007 May; 364(2):104-11. PubMed ID: 17386920
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACE inhibitory activity in enzymatic hydrolysates of insect protein.
    Vercruysse L; Smagghe G; Herregods G; Van Camp J
    J Agric Food Chem; 2005 Jun; 53(13):5207-11. PubMed ID: 15969498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simplified enzymatic assay of angiotensin-converting enzyme in serum.
    Groff JL; Harp JB; DiGirolamo M
    Clin Chem; 1993 Mar; 39(3):400-4. PubMed ID: 8383586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A simple radioassay for angiotensin-converting enzyme.
    Ryan JW; Chung A; Ammons C; Carlton ML
    Biochem J; 1977 Nov; 167(2):501-4. PubMed ID: 202255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.